Join us today at #VAM2026!
Dr. Mohamed Zayed will present "Emerging Therapies for Medical Management of Peripheral Arterial Disease" followed by Dr. Ali Alshawi presenting "VT09 - Anatomical Femoral to Anterior Tibial Bypass Graft."
#WashUSurgery#VascularSurgery#VAM#SVS
🚨 New JVS meta-analysis (Boya et al, 2026) on Transcatheter Arterialization of Deep Veins (TADV) for no-option CLTI patients facing up to 67% 1-yr major amputation rates with no surgical or endovascular options.
4 TADV studies (n=197) vs CLariTI SoC (n=180). 🧵 1/9
@AnahitaDua
This article discusses a #vascularsurgery resident's efforts to develop a computer vision–based AI training platform designed for environments where traditional surgical education models are simply not feasible. Read more here: https://t.co/7qvb0PoxdI
🚨 New JVS meta-analysis (Boya et al, 2026) on Transcatheter Arterialization of Deep Veins (TADV) for no-option CLTI patients facing up to 67% 1-yr major amputation rates with no surgical or endovascular options.
4 TADV studies (n=197) vs CLariTI SoC (n=180). 🧵 1/9
@AnahitaDua
🎯 BOTTOM LINE: TADV is no longer experimental for no-option CLTI.
The next questions aren't "TADV vs no TADV" (an RCT may be unethical) they're:
→ how do we keep the DVA circuit open?
→ refine reintervention strategy
→ optimize patient selection
📄 JVS 2026;83:482–92. 9/9